Sarc
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
Immunotherapy Drug Pembrolizumab Improves Outcomes for Patients with Soft Tissue Sarcoma
Pembrolizumab added to standard care for advanced limb soft tissue sarcoma significantly improved disease-free survival in the SU2C-SARC032 trial, led by researchers from the University of Pittsburgh, UPMC, Duke University, and Princess Margaret Cancer Centre, published in The Lancet.
© Copyright 2024. All Rights Reserved by MedPath